CACNA1C and cardiac hypertrophy: Re-expression of the identified isoform by missplicing of the Cav1.2 gene, Cacna1c, promoted proteasomal degradation of wild-type Cav1.2, thus explaining the reported decreased expression and activity of Cav1.2 in cardiac hypertrophy (Hu et al., 2016).